A therapeutic and cosmetic ingredient which is 1,000 times more effective than mānuka honey and 20-30 times more effective than tea tree oil against gram positive bacteria
Founded in 2016, Manuka Bisocience has grown from a single product company, to a global category leader in mānuka oil with multiple brands, a growing international customer base, a pipeline of botanical medicines undergoing clinical and consumer studies, a strong global IP position, and ownership of the largest mānuka oil supply in New Zealand and the world.
With a global team of research scientists, dermatologists, formulation chemists and aestheticians, Manuka Bioscience is focused on creating topical solutions for a multitude of skin concerns, including skin and wound infections that don’t contribute to AMR.
Manuka Bioscience has a promising pipeline of advanced cosmeceutical and dermatological products and ingredients. These efficacious B2B and B2C solutions are supported by science and research, with preclinical research programmes and clinical trials focusing on formulations targeting at specific medical indications.
Manuka Bioscience is committed to the sustainable growing, processing and development of East Cape mānuka oil. Grown, harvested and distilled in collaboration with local iwi, the partnership benefits both the natural environment and the rural community. In a region where poverty is high and jobs are scarce, the mānuka oil industry is creating a sustainably industry in the East Cape region of New Zealand.
Manuka Bioscience is now a Certified B Corporation. Learn how Manuka Bioscience is making waves with its game-changing sustainability practices in the industry.
Increasingly, people prefer food, cosmetics and medicines that have natural ingredients. Natural products are considered a healthier option, with fewer adverse reactions and better for the environment. Over the last
International health agencies such as the United Nations and the World Health Organisation have declared escalating antimicrobial resistance (AMR) as one of the gravest and most urgent threats to global
By developing skincare that works naturally to keep skin clean, we help our customersmaintain the health and beauty of their skin while joining together in the fight againstantimicrobial resistance (AMR).
RECEIVERSHIP
On 31 January 2025 Daniel Stoneman and Neale Jackson of Calibre Partners were appointed joint
Receivers of Manuka Bioscience Limited and Manuka Biologicals Limited (Both in Receivership).
As the Companies are in receivership, we are unable to provide any exchanges, returns, refunds or
credits for products purchased prior to receivership (31 January 2025), unless specifically required by
any statute. The Receivers are able to provide exchanges, returns, refunds or credits for purchases
made during the receivership provided the product is returned within 14 days of purchase.
The Receivers shall have no personal liability under or in respect of any sale transaction, and in
particular, to the maximum extent permitted by law, any personal liability of the Receivers in respect of
any guarantee, warranty or undertaking relating to any goods sold is excluded.
In proceeding to complete any sale transaction, the Customer by doing so agrees that the sale
transaction and the supply of any goods in relation to it is subject to these terms.
If you have any questions regarding the Receiverships of these two entities, do not hesitate to contact
Calibre Partners at contact@calibrepartners.co.nz.
Manuka Bioscience is a botanical science company that is unlocking the true potential of East Cape mānuka oil by developing evidence backed, mānuka oil based ingredients, cosmeceuticals and therapeutics.
